Pancreatic neuroendocrine tumors, or PNETs, also known as Islet cell tumors, are rare tumors that arise from hormone-producing cells of the pancreas. These specialized cells, known as neuroendocrine cells, produce hormones that regulate several important bodily functions, including blood sugar regulation, digestion, and metabolism.
Unlike the more common pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumors usually grow more slowly and may have a better prognosis when detected early. However, their behavior can vary widely depending on the type of tumor, its size, the hormones it produces, and whether it has spread to other parts of the body.
Neuroendocrine tumors of the pancreas constitute only 1-2% of all cases of pancreatic cancer. Even though this type of tumor is rare, there has been a rise in its diagnosis because of improved imaging techniques.
Some pancreatic neuroendocrine tumors produce excessive amounts of hormones, leading to specific clinical syndromes. These are referred to as functional tumors. Other tumors do not produce active hormones and are called nonfunctional tumors. Nonfunctional tumors may remain silent for long periods and come to light incidentally during imaging tests performed for other reasons.
Several factors influence the treatment of pancreatic neuroendocrine tumors, including tumor type, disease stage, hormone production, and the patient's overall condition. There are many methods that have made great strides in treating this disease.
The pancreas can be introduced as a gland located in the upper abdomen. It performs two essential roles:
These hormones include:
Pancreatic neuroendocrine tumors develop from these endocrine cells. When these cells become cancerous, they may grow uncontrollably and form tumors that can affect hormone production and spread to other organs such as the liver, lymph nodes, or bones.
Pancreatic neuroendocrine tumors are classified based on whether they produce hormones.
Functional tumors produce excess hormones, leading to specific clinical symptoms. Common types include:
Insulinomas produce excessive insulin, causing low blood sugar (hypoglycemia). Symptoms may include:
Insulinomas are usually small and often benign.
Gastrinomas produce excessive gastrin, a hormone that stimulates gastric acid secretion. This condition is known as Zollinger–Ellison syndrome and may cause:
Gastrinomas may be malignant and can spread to the liver or lymph nodes.
Glucagonomas produce high levels of glucagon, leading to symptoms such as:
Somatostatinomas produce excess somatostatin, which inhibits the release of several other hormones. Symptoms may include:
VIPomas produce vasoactive intestinal peptide (VIP), which can cause:
Nonfunctional tumors do not produce active hormones. As a result, they often grow silently and may become large before causing symptoms. Symptoms generally appear/occur when the tumor presses on nearby organs or spreads to other parts of the body.
Symptoms vary depending on whether the tumor produces hormones. Common symptoms include:
Functional tumors may produce additional symptoms related to hormone excess. For example:
Because these symptoms may resemble other medical conditions, diagnosis can sometimes be delayed.
The exact reason for pancreatic neuroendocrine tumors is not fully understood. However, genetic mutations in neuroendocrine cells are believed to play an important role. Several conditions increase the chances of developing these tumors.
Certain inherited conditions are strongly associated with pancreatic neuroendocrine tumors. These include:
These tumors are more commonly diagnosed in adults between the ages of 40 and 60.
People with a family history of endocrine tumors may have an increased risk.
Diagnosing pancreatic neuroendocrine tumors often requires multiple tests to identify the tumor and determine its behavior.
Doctors begin by reviewing symptoms, hormone-related problems, and family medical history.
Laboratory tests may detect abnormal hormone levels. Examples include:
Urine tests may detect breakdown products of hormones.
Imaging techniques help identify the tumor's location. They also help identify if the cancer has spread. Commonly used imaging techniques are as follows:
A biopsy is an effective way to diagnose and confirm the issue, as it removes a tissue sample for examination under a microscope. Pathologists determine:
Neuroendocrine tumors are graded based on how quickly the cells grow. Grades include:
Tumor grade helps determine the best treatment approach.
Staging describes how far the tumor has spread. Stages involve:
Many pancreatic neuroendocrine tumors are diagnosed after they have spread to the liver, but effective treatment options may still be available.
Treatment depends on tumor type, stage, hormone production, and the patient's overall health. A multidisciplinary team usually develops the treatment plan.
Surgery is the most effective treatment when the tumor is localized. Common surgical procedures include:
Surgery may also remove metastatic tumors in the liver if possible.
The medicines include:
Targeted therapy medicines work on the body’s cancer growth signals. The medicines include:
Chemotherapy may be the option for aggressive or advanced tumors. Common chemotherapeutic agents are as follows:
Chemotherapy can help reduce tumors and prevent disease progression.
PRRT is a more sophisticated form of therapy for neuro In this therapy:
PRRT has shown promising results in cancer patients with advanced disease.
When cancer metastasizes to the liver, other treatment options may be:
The above procedures target cancer in the liver while sparing healthy liver tissue.
The prognosis for pancreatic neuroendocrine tumors varies widely. Factors affecting prognosis include:
Slow-growing tumors have a good prognosis, especially if detected early. Patients with advanced stages of the condition may live longer if it is well-managed.
Patients suffering from pancreatic neuroendocrine tumors need long-term care. Follow-up care may include:
Regular monitoring helps detect disease recurrence or progression. Lifestyle adjustments, nutritional support, and psychological counseling may also be helpful for long-term well-being.
Tender Palm Super-Speciality Hospital offers advanced Pancreatic Neuroendocrine Tumor treatment in Lucknow, India, at an affordable cost. We have a team of experienced pancreatic surgeons and endocrinology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, somatostatin analogue therapy, and targeted therapy. Our Pancreatic Surgery and Endocrinology team has decades of experience in successfully treating Pancreatic Neuroendocrine Tumor (Islet Cell Tumor) in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com